Mechanism of Immune Hyporesponsiveness Induced by Recipient- derived Immature Dendritic Cells in Liver Transplantation Rat△
2011-04-20LiLiShengningZhangJianghuaRanJingLiuZhuLiandLaibangLi
Li Li,Sheng-ning Zhang, Jiang-hua Ran, Jing Liu, Zhu Li, and Lai-bang Li
Department of Hepatobiliary Pancreatic Surgery, First People's Hospital of Kunming, Kunming Medical College, Liver Transplantation Center of Organ Transplantation Institute of Yunnan Province, Kunming 650011, China
LIVER transplantation is an effective strategy in tre- ating end-stage liver diseases, still post-transplan- tation rejection reaction, among other issues, hin- ders the development of liver transplantation. Cur- rently, the use of immature dendritic cells (imDC) has become a promising approach to induce immune tolerance or immune hyporesponsiveness.1imDC used in these appro- aches were donor-derived DC, which induces immune tolerance or immune hyporesponsiveness by targeting direct recognition. However, donor-derived imDC need to be harv- ested for a few days and transfused into the recipient 5-10 days before transplantation, which is practically impossible in a clinical setting where donor organs are mainly harvested from cadavers. Moreover, donor-derived imDC might be cleared by allogeneic reaction offsetting induced immune tolerance or immune hyporesponsiveness. The use of reci- pient-derived imDC, should avoid all these unfavorable fac- tors. In our study we further explored the underlying mech- anism of immune hyporesponsiveness induced by donor- antigen-unloaded recipient-derived imDC by transfusing these imDC into rats 1 day before liver transplantation.
MATERIALS AND METHODS
Experimental animal
Forty male Wistar rats, weighing 250-280 g and serving as recipient of liver transplantation, were purchased from Vital River Laboratory Animal Technology Co. Ltd., Beijing. Forty Sprague-Dawley (SD) rats weighing 220-250 g, were purchased from Laboratory Animal Center of Kunming Medical University, and served as the donors. All experimental procedures described below were approved by our institutional animal research committees and were in accordance with nationally approved guidelines for the treatment of laboratory animals.
Cell preparations and flow cytometry analysis
Recipient (Wistar rats)-derived imDC and mature DC (mDC) were obtained by treating DC with inhibitory cytokine interleukin 10 (IL-10) based on a modified version of the method described by Chen-Woan et al.2The phenotypes of mDCs and imDCs derived from bone marrow cells were assayed by cytofluorometry day 9 after culture. Cells (5× 106) were stained with FITC-conjugated anti-rat MHC class II and OX62 antibodies and PE-conjugated anti-rat CD80 and CD86 antibodies (Pharmingen, CA, USA).
Assignments of model animal
The SD-Wistar rat liver transplantation model was established with a modified two-cuff technique.3-5All rats were divided into 4 groups, with 10 donor rats and 10 recipient rats in each group. Rats in these groups were given corresponding treatment before or after transplantation. As for control group, rats were not given any treatment. In the cyclosporine A (CsA) group, recipient rats were treated with CsA (10 mg·kg-1·d-1) starting day 2 after the transplanation. In the mDC group, recipients were given Wistar rat derived mDCs (1×106/rat) via dorsal vein of the penis, 1 day before the transplantation. For the imDC group, Wistar rat derived imDCs (1×106/rat) were given via dorsal vein of the penis, 1 day before the transplantation. The dosages of mDC and imDC were determined with reference to related literature.6,7Rats in mDC and imDC groups underwent two-cuff orthotopic liver transplantation 1 day after cell transfusion.
Determination of post-transplantational survival time
For each group, 5 recipient rats were kept for determination of post-transplantation survival. If animals of any group died at varied time points due to errors during surgery or infection, a replacement animal would be added accordingly.
Blood tests
At day 10 after transplantation, 5 randomly selected rats were executed and blood samples were obtained via the peritoneal vein. Blood sample (2-3 mL) was centrifuged for 10 minutes at 4°C (1500 g). Supernatant (600 μL) was obtained and preserved at -70°C until all the samples were ready for measurement of alanine aminotransferase (ALT), total bilirubin (TBIL), IL-2, interferon gamma (IFN-γ), IL-4, and IL-10 using ELISA reagent kits (Biosource, CA, USA).
Assessment of rejection reaction in recipient rats
Two liver samples were harvested from each Wistar rat at execution. One of the samples was fixed in 10% neutral formalin solution and embedded with paraffin. Sections were stained with haematoxylin and eosin (HE). The other sample was wrapped in tinfoil and preserved in liquid nitrogen until Western blot assay. The acute rejection were observed and scored by the staff of Pathological Teaching and Research Unit of the Kunming Medical University, and graded according to Banff classification.8-10For Grade 0, no definite evidence of rejection reaction is seen, with borderline inflammatory cell infiltration in the hepatic artery, portal vein, and bile duct of the portal area. Grade Ⅰrejection is described as mild rejection; inflammatory cell infiltration can be found in bile ducts and blood vessels among some of the portal area, with a few inflammatory cells confined to a few portal areas. A Grade Ⅱ reaction is described as moderate rejection; inflammatory cell infiltration can be seen in bile ducts and blood vessels among most portal areas. A Grade Ⅲ reaction is defined as severe rejection; inflammatory cell infiltration further spreads into peri-portal area, and moderate to severe phlebitis can be found in portal area as well as hepatic parenchyma, with hepatic cellular necrosis around affected veins.
Immunohistochemical staining
The formalin-fixed, paraffin-embedded liver tissue was used to determine the expression level of Fas/FasL with streptavidin-peroxidase conjugate (SP) method as described in the protocol of the reagent kit (Maixin Bio., Fujian, China). FAS and FAS-ligand (product identification serial number RAB-1090 and RAB-002 respectively) were purchased from Fuzhou Maxim Biotech Inc.
All slices were examined under light microscopy at a magnification of 400. Fas/FasL-positive hepatic cells were with brownish nuclei and/or cytoplasm. Ten visual fields in each slice were randomly selected to calculate the Fas/ FasL-positive hepatic cells number (N1) and total hepatic cell number (N). The positive rate of Fas/FasL expression was calculated by N1/N×100%.
Protein extraction from liver tissue
Proteins were extracted using radioimmunoprecipitation assay (RIPA) buffer according to the manufacturer's protocol (Pierce, IL, USA). Total 50 mg of liver tissue was harvested and subsequently homogenized in 0.5 mL RIPA buffer containing 1.5×protease inhibitor cocktail on ice for 30 minutes. After centrifugation for 15 minutes at 4°C (13 500 g), the supernatant was obtained and the protein concentration was determined by BCA Protein Assay kit (Pierce, USA).
Western blot assay
Proteins (30 μg) were separated on sodium dodecyl sulfate-polyacrylamidegel electrophoresis (SDS-PAGE) and electrotransferred onto a nitrocellulose membrane. And the membrane was blocked with TBST [Tris-hydroxymethyl aminomethane (Tris) solution with 5% bovine serum albumin and 0.05% Tween-20]. The membrane was cultured with rabbit anti-rat Foxp3 monoclonal antibody at the dilution of 1:500 (e-Bioscience, CA, USA) and rabbit anti-rat β-actin monoclonal antibody at the dilution of 1:50 000 (Sigma, St. Louis, MO, USA) respectively at 4°C overnight. After washing, the membrane was incubated with HRP labeled anti-rabbit IgG (Pierce, IL, USA) at the dilution of 1:2500 for 40 minutes at room temperature. Finally, the bands were visualized using the enhanced chemiluminescence detection system as recommended by the manufacturer. Quantity one 4.1 software system (Bio-Rad, CA, USA) was used to calculate gray scale intensity. β-actin was served as an internal control.
Statistical analysis
SPSS 13.0 software package was used in the analysis. Data were shown as x± s. Analysis of variance was used to determine whether the differences in means between the groups were statistically significant. The means of Banff scores between different groups were compared with rank sum test. Differences in survival time were tested with Log-rank method, with test level α=0.05.
RESULTS
Phenotype of mDC and imDC
At least 88% of mDC and imDC were OX62-positive, which was the characteristic marker for DCs. imDC expressed lower level of MHC-II and co-stimulatory molecules (CD86, CD80) compared with mDC (Fig. 1).
Post-transplantational survival time of Wistar rats
The survival time of both the CsA and imDC groups was signi- ficantly longer than that of the control group as well as the mDC group (all P<0.05). However, no significant differences were seen between the imDC and CsA groups (P>0.05). Addi- tionally, no significant differences were detected when com- paring the control group with mDC group (P>0.05) (Table 1).
Post-transplantational liver function and cytokine level
ALT (P<0.05), TBIL (P<0.05), IL-2 (P<0.01), and IFN-γ (P<0.01) levels in the control and mDC groups were significantly higher than those in the CsA and imDC groups, while IL-4 and IL-10 levels in the control and mDC groups were significantly lower than those in the CsA and imDC groups (all P<0.01) (Table 2).

Figure 1. Flow cytometry analysis of the phenotype of bone marrow-derived mature dendritic cells (mDC) and immature DC (imDC). The phenotype of mDCs and imDCs derived from bone marrow were analyzed by cytofluorometry on day 9 of culture. Cells (5×106) were stained with FITC-conjugated anti-rat MHC class II and OX62 antibodies and PE-conjugated anti-rat CD86 and CD80 antibodies respectively. Results were similar in five independent experiments. Upper row: mDC; lower row: imDC.

Table 1. Post-operational comparison of survival time of four groups (n=5)

Table 2. Post-operational comparison of liver function and cytokine level of four groups§ (n=5)
Histopathological features of recipient liver tissue after transplantation
Grade Ⅲ rejection, as evaluated with Banff classification, was observed in the control and mDC groups, with massive monocyte infiltration in the portal area. Both bile ducts and blood vessels were affected and the structure of the hepatic lobule was destroyed. Focal hemorrhage and necrosis were also found. As for the CsA and imDC groups, a few monocytes could be found in the portal area, but the hepatic parenchyma, bile ducts, and blood vessels were not affected. Borderline inflammatory cell infiltration, which was rated as Grade 0 rejection by Banff classification, could be seen in hepatic arteries, portal veins, and bile ducts of the portal area (Fig. 2). Banff scores at day 10 after transplantation for each group are shown in Table 3.
Fas/FasL expression in recipient liver tissue at day 10 after transplantation
The rate of Fas-positive expression in liver cells at day 10 after transplantation for the control, mDC, CsA, and imDC groups were 7.66±0.89, 6.29±0.47, 2.54±0.44, and 2.16±0.39, respectively. FasL expression rates in liver cells in CsA group and imDC group were 5.14±0.86 and 5.22±0.69, respectively. FasL expression was also found in the inflammatory cells in portal area. Low level of FasL expression was found in either the control or mDC groups. Both the positive rates of Fas and FasL expression in CsA and imDC groups were significantly lower than those in the other two groups (all P<0.01) (Figs. 3 and 4).
Expression of Scurfin protein encoded by Foxp3 in recipient liver tissue at day 10 after transplantation
Scurfin is encoded by a specific transcription factor Foxp3 and expressed on the surface of CD4+CD25+regulatory T cell. On day 10 after transplantation, expression level of Scurfin in imDC group (1.34±0.29) was significantly higher than that in the control (0.72±0.13), CsA (0.37±0.11), and mDC (0.78±0.17) groups (all P<0.05). Scurfin expression level of CsA group was the lowest among the four groups (Fig. 5).

Figure 2. Histopathological features in recipient liver tissue at day 10 after transplantation. HE staining ×400A. control group; B. CsA group; C. mDC group; D. imDC group.

Table 3. Banff scores of recipient liver tissue at day 10 after transplantation in each group (n=5)

Figure 3. Immunohistochemical assay of Fas expression in recipient liver at day 10 after transplantation. SP ×400A. control group; B. CsA group; C. mDC group; D. imDC group.

Figure 4. Immunohistochemical assay of Fas-L expression in recipient liver tissue at day 10 after transplantation. SP ×400A. control group; B. CsA group; C. mDC group; D. imDC group.

Figure 5. Western blot analysis of Scurfin expression encoded by Foxp3 at day 10 after transplantation.A. control group; B. CsA group; C. mDC group; D. imDC group.
DISCUSSION
Being an immunologically privileged organ, liver transplantation provokes much less rejection reaction as compared with other organs (such as heart, lung, pancreas, and kidney); however, rejection reaction after transplantation is a pending issue in current clinical practice.11Two signal pathways are involved in rejection reaction of allogeneic graft: direct and indirect recognition. Given the important role of direct and indirect recognition in graft rejection, numerous studies have sought to induce immune hyporesponsiveness or immune tolerance by targeting direct and indirect recognition.12-14Previously, it was suggested that direct recognition was the predominant pathway in the acute rejection, while indirect recognition mainly occurred in the chronic rejection reaction. However, Benham et al's studies have revealed that indirect recognition was equally important in acute rejection.15Currently, few studies have investigated the role of indirect recognition in acute rejection reaction.
In our study, we used immature dendritic cells, which express low level of MHC and co-stimulatory molecules, to interfere with indirect recognition and thus block the activation of T cells and significantly protect allogeneic liver graft in rats. The protection was seen similar to that of CsA. Results of the study indicated that liver function in the imDC and CsA groups was continuously being restored after transplantation, which was significantly different from that in the control or mDC groups. Microscopic observation also showed that imDC markedly inhibited acute rejection, while mDC established no inhibition. imDC might have induced immune hyporesponsiveness of non-antigen-spe- cific T cell by the following pathways.
Induction of apoptosis in T cells
Immunohistochemical assay revealed elevated expression of Fas protein in the control and mDC groups at day 10 after transplantation, while little Fas expression was seen in either the CsA or imDC groups. This suggested that the binding of FasL on the surface of T cells to Fas protein on surface of hepatic cells induced necrosis in the hepatic cells, and thus led to acute rejection reaction in liver graft. Few necrotic cells were found in either the imDC or CsA groups, with no marked rejection reaction. These findings suggest that imDC significantly inhibits rejection reaction. On the contrary, expression levels of FasL were higher in imDC group and CsA group than those in mDC group and control group. The binding of FasL on the surface of hepatic cells to the Fas protein on T cells induced apoptosis of T cells and therefore inhibited their immune response. Hence, imDC might have promoted T cell apoptosis and suppressed immune response by increasing FasL expression in hepatic cells.
Selective activation of type 2 helper T cell by imDC
Mosmann et al16discovered that CD4+T cells in rats differentiated into Th1 and Th2 subsets when stimulated. They secrete different cytokines, such as IL-2 and IFN-γ secreted by Th1 subset, and IL-4 and IL-10 secreted by Th2 subset. Th1 and Th2 cells cross-inhibit each other's differentiation and function. Elevated proliferation of Th2 down-regulates the development of Th1, and vice versa. In recent years, a handful of studies have indicated that Th1 had a major role in acute rejection reaction after liver transplantation.17-19Th1 cell is an important effector cell in mediating graft rejection; and large amounts of Th1 cells can be detected in graft organs when acute rejection reaction occurs. IL-2 and IFN-γ produced by Th1 cell are critical cytokines in acute rejection. On the other hand, Th2 subset of helper T cells mediated immune hyporesponsiveness or tolerance. Wang et al20found that expression of IL-2 increased in peripheral blood during acute rejection after transplantation, while Gibelli et al21discovered that IL-2 receptor antagonist basiliximab significantly reduced incidence of acute rejection after transplantation.
Our study has shown that serum IL-4 and IL-10 levels were markedly higher in the CsA and imDC groups than those in the control and mDC groups, while IL-2 and IFN-γ were significantly lower than those in control group and mDC group. These findings suggest that CsA and imDC might suppress the immune response by inducing differentiation from Th0 into Th2.22In the control and mDC groups, Th0 cells might have developed into Th1 and thereby lead to acute rejection.
Induction of regulatory T cell (Tre)
Induction of Tre by imDC is another possible explanation to immune hyporesponsiveness induced by imDC in liver transplantation rats. Tre has an important role in both autoimmune response and immune response against pathogens. It has been shown that positive feedback regulation exists between imDC and Tre,23suggesting that we could manipulate the immune response by targeting these cells, thereby achieving long-term graft survival.
Foxp3 is a new member of Forkhead/Winged Helix transcription factor family. It encodes Scurfin protein, which is mainly expressed on CD4+CD25+Tre cells. Proliferation and immune regulation of CD4+CD25+Tre cells were related to transcription factor Foxp3, which was regarded as a specific surface marker of these cells.24,25It was also reported that immune regulation of CD4+CD25+Tre cells was related to expression level of Scurfin protein.26
In our study, Western blot assay revealed that expression level of Scurfin protein in imDC group was mar- kedly higher than that in the other 3 groups. Expression of Scurfin protein was significantly lower in CsA group when comparing to other groups (P<0.05), which indicated CsA might be involved in decreased proliferation of CD4+CD25+Tre cells. CsA suppresses immune response by effectively inhibiting the transcription of IL-2, indicating that CsA might damage CD4+CD25+Tre cells.27These evidences were in line with the assumption that imDC might induce immune hyporesponsiveness of T cells by inducing proliferation of Tre.
In conclusion, donor-antigen-unloaded recipient-deri- ved imDC significantly prolonged graft survival by interfering with indirect recognition. The following processes might be involved in immune hyporesponsiveness of liver graft induced by imDC: T cell apoptosis, selective activation of Th2 subset, induction of the shift of Th1/Th2 balance, and proliferation of regulatory T cells. However, as imDCs responsible for the induced hyporesponsiveness mature in human body, immune tolerance would eventually disappear. Therefore, more studies are needed on how to achieve long-term immune hyporesponsiveness, and how to induce specific immune tolerance.
1. Barratt-Boyes SM, Thomson AW. Dendritic cells: tools and targets for transplant tolerance. Am J Transplant 2005; 5:2807-13.
2. Chen-Woan M, Delaney CP, Fournier V, et al. A new protocol for the propagation of dendritic cells from rat bone marrow using recombinant GM-CSF, and their quantification using the mAb OX-62. J Immunol Methods 1995; 178:157-71.
3. Sun JH, Zeng QH, Wu MC. Experience with orthotopic rat liver transplantation. Chin Med J (Engl) 1990; 103:142-5.
4. Kamada N, Calne RY. Orthotopic liver transplantation in the rat. Technique using cuff for portal vein anastomosis and biliary drainage. Transplantation 1979; 28:47-50.
5. Kashfi A, Mehrabi A, Pahlavan PS, et al. A review of various techniques of orthotopic liver transplantation in the rat. Transplant Proc 2005; 37:185-8.
6. Pêche H, Trinité B, Martinet B, et al. Prolongation of heart allograft survival by immature dendritic cells generated from recipient type bone marrow progenitors. Am J Transplant 2005; 5:255-67.
7. Bériou G, Pêche H, Guillonneau C, et al. Donor-specific allograft tolerance by administration of recipient-derived immature dendritic cells and suboptimal immunosuppression. Transplantation 2005; 79:969-72.
8. Demetrius AJ, Batts KP, Dhillon AP, et al. Banff schema for grading liver allograft rejection: an international consensus document. Hepatology 1997; 25:658-63.
9. Hübscher S. Diagnosis and grading of liver allograft rejection: a European perspective. Transplant Proc 1996; 28:504-7.
10. Höroldt BS, Burattin M, Gunson BK, et al. Does the Banff rejection activity index predict outcome in patients with early acute cellular rejection following liver transplantation? Liver Transpl 2006;12:144-51.
11. Pompili M, Mirante VG, Rapaccini GL, et al. Liver transplantation. Ann Ital Med Int 2004; 19:20-35.
12. Tiao MM, Lu L, Tao R, Harnaha J, et al. Application of recipient-derived dendritic cells to induce donor-specific T-cell hyporesponsiveness. Transplant Proc 2004; 36: 1592-4.
13. Gould DS, Auchincloss H Jr. Direct and indirect recognition: the role of MHC antigens in graft rejection. Immunol Today 1999; 20:77-82.
14. Game DS, Lechler RI. Pathways of allorecognition: implications for transplantation tolerance. Transpl Immunol 2002; 10:101-8.
15. Benham AM, Sawyer GJ, Fabre JW. Indirect T cell allorecognition of donor antigens contributes to the rejection of vascularized kidney allografts. Transplantation 1995; 59:1028-32.
16. Mosmann TR, Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 1996; 17:138-46.
17. Chen Y, Chen J, Liu Z, et al. Relationship between TH1/TH2 cytokines and immune tolerance in liver transplantation in rats. Transplant Proc 2008; 40:2691-5.
18. Han FH, Zhang ZD, Li YC, et al. The monitoring of Th1/Th2 cytokine expression and its significance to the diagnosis of acute rejection after pancreatic transplantation. Sichuan Da Xue Xue Bao Yi Xue Ban 2006; 37:587-91.
19. Mariotti J, Foley J, Ryan K, et al. Graft rejection as a Th1-type process amenable to regulation by donor Th2- type cells through an interleukin-4/STAT6 pathway. Blood 2008; 112:4765-75.
20. Wang YL, Tang ZQ, Gao W, et al. Influence of Th1, Th2, and Th3 cytokines during the early phase after liver transplantation. Transplant Proc 2003; 35:3024-5.
21. Gibelli NE, Pinho-Apezzato ML, Miyatani HT, et al. Basilixi- mab-chimeric anti-IL2-R monoclonal antibody in pediatric liver transplantation: comparative study. Transplant Proc 2004; 36:956-7.
22. Pellegrini P, Totaro R, Contasta I, et al. CD30 antigen and multiple sclerosis: CD30, an important costimulatory molecule and marker of a regulatory subpopulation of dendritic cells, is involved in the maintenance of the physiological balance between TH1/TH2 immune respon- ses and tolerance. The role of IFNbeta-1a in the treatment of multiple sclerosis. Neuroimmunomodulation 2005; 12: 220-34.
23. Min WP, Zhou D, Ichim TE, et al. Inhibitory feedback loop between tolerogenic dendritic cells and regulatory T cells in transplant tolerance. Immunol 2003; 170:1304-12.
24. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003; 299:1057-61.
25. Albert MH, Liu Y, Anasetti C, et al. Antigen-dependent suppression of alloresponses by Foxp3-induced regulatory T cells in transplantation. Eur J Immunol 2005; 35:2598- 607.
26. Fontenot JD, Rasmussen JP, Williams LM, et al. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 2005; 22:329-41.
27. Wang H, Zhao L, Sun Z, et al. A potential side effect of cyclosporine A: inhibition of CD4+CD25+regulatory T cells in mice. Transplantation 2006; 82:1484-92.
杂志排行
Chinese Medical Sciences Journal的其它文章
- Echocardiographic Monitoring of Cardiac Parameters after Mitral Valve Replacement with the Preservation of Subvalvular Structures
- Pathological and High Resolution CT Findings in Churg-Strauss Syndrome
- Observation of Insulin Exocytosis by a Pancreatic β Cell Line with Total Internal Reflection Fluorescence Microscopy
- Changes in Plasma Angiotensin II and Circadian Rhythm of Blood Pressure in Hypertensive Patients with Sleep Apnea Syndrome Before and After Treatment
- Influence of Shenqing Recipe on Morphology and Quantity of Colonic Interstitial Cells of Cajal in Trinitrobenzene Sulfonic Acid Induced Rat Colitis△
- Primary Clinical Evaluation of the Joint Replacement for the Treatment of the First Metatarsophalangeal Arthritis
